136 related articles for article (PubMed ID: 38935068)
1. Optimizing in silico drug discovery: simulation of connected differential expression signatures and applications to benchmarking.
Gonzalez Gomez C; Rosa-Calatrava M; Fouret J
Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38935068
[TBL] [Abstract][Full Text] [Related]
2. Reconciling multiple connectivity scores for drug repurposing.
Samart K; Tuyishime P; Krishnan A; Ravi J
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013329
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
Wang Y; Yella J; Jegga AG
Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
[TBL] [Abstract][Full Text] [Related]
4. Multiscale Virtual Screening Optimization for Shotgun Drug Repurposing Using the CANDO Platform.
Hudson ML; Samudrala R
Molecules; 2021 Apr; 26(9):. PubMed ID: 33925237
[TBL] [Abstract][Full Text] [Related]
5. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.
Li Y; Yang Y; Tong Z; Wang Y; Mi Q; Bai M; Liang G; Li B; Shu K
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647153
[TBL] [Abstract][Full Text] [Related]
6. Prioritizing therapeutics for lung cancer: an integrative meta-analysis of cancer gene signatures and chemogenomic data.
Fortney K; Griesman J; Kotlyar M; Pastrello C; Angeli M; Sound-Tsao M; Jurisica I
PLoS Comput Biol; 2015 Mar; 11(3):e1004068. PubMed ID: 25786242
[TBL] [Abstract][Full Text] [Related]
7. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
Karatzas E; Kolios G; Spyrou GM
Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
[TBL] [Abstract][Full Text] [Related]
8. Simulating multiple variability in spatially resolved transcriptomics with scCube.
Qian J; Bao H; Shao X; Fang Y; Liao J; Chen Z; Li C; Guo W; Hu Y; Li A; Yao Y; Fan X; Cheng Y
Nat Commun; 2024 Jun; 15(1):5021. PubMed ID: 38866768
[TBL] [Abstract][Full Text] [Related]
9. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
[TBL] [Abstract][Full Text] [Related]
10. Leveraging Big Data to Transform Drug Discovery.
Glicksberg BS; Li L; Chen R; Dudley J; Chen B
Methods Mol Biol; 2019; 1939():91-118. PubMed ID: 30848458
[TBL] [Abstract][Full Text] [Related]
11. Influence of batch effect correction methods on drug induced differential gene expression profiles.
Zhou W; Koudijs KKM; Böhringer S
BMC Bioinformatics; 2019 Aug; 20(1):437. PubMed ID: 31438848
[TBL] [Abstract][Full Text] [Related]
12. gene2drug: a computational tool for pathway-based rational drug repositioning.
Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
[TBL] [Abstract][Full Text] [Related]
13. DrSim: Similarity Learning for Transcriptional Phenotypic Drug Discovery.
Wei Z; Zhu S; Chen X; Zhu C; Duan B; Liu Q
Genomics Proteomics Bioinformatics; 2022 Oct; 20(5):1028-1036. PubMed ID: 36182102
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive evaluation of connectivity methods for L1000 data.
Lin K; Li L; Dai Y; Wang H; Teng S; Bao X; Lu ZJ; Wang D
Brief Bioinform; 2020 Dec; 21(6):2194-2205. PubMed ID: 31774912
[TBL] [Abstract][Full Text] [Related]
15. Benchmarking of 4C-seq pipelines based on real and simulated data.
Walter C; Schuetzmann D; Rosenbauer F; Dugas M
Bioinformatics; 2019 Dec; 35(23):4938-4945. PubMed ID: 31134276
[TBL] [Abstract][Full Text] [Related]
16. MaSS-Simulator: A Highly Configurable Simulator for Generating MS/MS Datasets for Benchmarking of Proteomics Algorithms.
Awan MG; Saeed F
Proteomics; 2018 Oct; 18(20):e1800206. PubMed ID: 30216669
[TBL] [Abstract][Full Text] [Related]
17. simAIRR: simulation of adaptive immune repertoires with realistic receptor sequence sharing for benchmarking of immune state prediction methods.
Kanduri C; Scheffer L; Pavlović M; Rand KD; Chernigovskaya M; Pirvandy O; Yaari G; Greiff V; Sandve GK
Gigascience; 2022 Dec; 12():. PubMed ID: 37848619
[TBL] [Abstract][Full Text] [Related]
18. A gene-signature progression approach to identifying candidate small-molecule cancer therapeutics with connectivity mapping.
Wen Q; Kim CS; Hamilton PW; Zhang SD
BMC Bioinformatics; 2016 May; 17(1):211. PubMed ID: 27170106
[TBL] [Abstract][Full Text] [Related]
19. Open-source chemogenomic data-driven algorithms for predicting drug-target interactions.
Hao M; Bryant SH; Wang Y
Brief Bioinform; 2019 Jul; 20(4):1465-1474. PubMed ID: 29420684
[TBL] [Abstract][Full Text] [Related]
20. Scoring functions for drug-effect similarity.
Struckmann S; Ernst M; Fischer S; Mah N; Fuellen G; Möller S
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32484516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
